Introduction
Diltiazem, a calcium channel blocker, is now commonly used in the treatment of various cardiovascular diseases, such as hypertension, ischaemic heart disease, and supraventricular arrhythmias. This drug produces toxicity such as hypotension and bradyarrhythmias in the case of excessive administration. Case reports of its overdose are increasing in number, but to-date, only one case with an overdose of newer sustained-release preparation has been reported. Here, a rare case of sustained-release diltiazem overdose which showed excellent efficacy of gastrointestinal decontamination is described.
Case report
A 52-year-old Japanese woman with essential hypertension was admitted to our hospital. Physical examination showed that she was 135 cm in height and weighed 43 kg. Blood pressure was 156/100 mm Hg and heart rate was 80 bpm under treatment with 100 mg of sustained-release diltiazem, 5 mg of enalapril, and 2 mg of trichlormethiazide. On the second day of hospitalisation, she complained of nausea, with vacant press-through packages of a 7-day supply of all these drugs beside her. An anamnesis confirmed that she had erroneously taken them all at once 30 min before. Considering her body size, these drug doses were extremely high. Hypotension and bradycardia were not initially apparent ( Figure 1 ) and thus the patient's nausea was likely to be a gastrointestinal symptom. Intravenous infusion of crystalloid was started immediately and 0.85 g of calcium gluconate was intravenously injected. Upon subsequent gastric lavage with a nasogastric tube for approximately 1 h, massive pill fragments were found in the effluent. The patient was lavaged with 50 g of activated charcoal Blood pressure and heart rate decreased progressively. After 14 h, the lowest levels of 120/62 mm Hg in blood pressure and a 40 bpm in heart rate were observed. Both of these haemodynamic changes gradually recovered without additional treatment (ie, using atropine, catecholamines, and cardiac pacing). No heart block or junctional escape was observed. Serum diltiazem concentration 10 h after the ingestion (329 ng/ml) was about six times higher than that necessary to lower blood pressure in Japanese hypertensive patients. 1 By contrast, serum levels of enalapril (51.5 ng/ml) or trichlormethiazide (6.9 ng/ml) 10 h after the ingestion were not elevated probably due to their fast clearance. Although enalapril and trichlormethiazide were also taken in excess, their haemodynamic effects were considered to be minimal because of the small change in blood pressure as compared with the change in heart rate, and because of their low serum concentration 10 h after ingestion.
Discussion
For the treatment of diltiazem overdose, 2-4 gastrointestinal decontamination and calcium injection have been recommended. 4 Most cases, however, with hypotension or bradycardia require inotropic supports or cardiac pacing. [2] [3] [4] It is assumed that appearance of haemodynamic changes due to sustained-release diltiazem might be delayed and that gastrointestinal decontamination might be quite effective shortly after its ingestion. However, these presumptions had not been proved because the only reported case 5 with sustained-release diltiazem overdose, who arrived at the hospital 6 to 7 h after the ingestion, required inotropic supports and cardiac pacing. By contrast, the subject of the present study took an overdose of sustained-release diltiazem while in the hospital and intensive gastrointestinal decontamination was performed shortly after its ingestion, and thus the haemodynamic changes without intensive cardiac supports could be followed up. Accordingly, this is the first report that really indicates the delayed appearance of toxicity of sustained-release diltiazem: maximal haemodynamic changes appeared 14 h after ingestion. The present case also demonstrated the excellent efficacy of gastrointestinal decontamination. Therefore, this case report teaches us a fundamental lesson that in patients with sustained-release diltiazem, blood pressure and heart rate levels should be followed up carefully after an intensive gastrointestinal decontamination since severe hypotension and bradycardia might appear later. It should be noted that the newer preparation of sustained-release diltiazem should be followed up somewhat differently than the older preparation.
